Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis ; volume:04 ; number:03 ; year:2020 ; pages:e245-e254
TH open ; 04, Heft 03 (2020), e245-e254
- Beteiligte Personen und Organisationen
-
van Hout, Ben
Hawe, Emma
Cohen, Alexander T.
- DOI
-
10.1055/s-0040-1716496
- URN
-
urn:nbn:de:101:1-2020121710182160645983
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- van Hout, Ben
- Hawe, Emma
- Cohen, Alexander T.
Ähnliche Objekte (12)
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment
Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment
Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment
Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort